Solas BioVentures

Solas BioVentures

Chattanooga, Tennesseesolasbio.com

Overview

Solas BioVentures is a venture capital firm that invests exclusively in the life sciences industry, focusing on early-stage biopharmaceuticals, medical devices, digital health technologies, and related opportunities in medicine. The firm maintains a founder-centric approach to enable breakthrough medicine and technology innovation, aiming to positively transform the standard of care and patient outcomes.

Year Founded

2014

Portfolio Companies

11

Investments

CompanyDateStageLead
Francis MedicalJan 2025Series CLead
iO UrologyMar 2024Series ALead
Vektor MedicalFeb 2024Series ALead
Basking BiosciencesFeb 2024Series CCo-investor
Arrivo BioVenturesNov 2023Series BCo-investor

Key People

C David Adair

Managing Partner Co-Founder

Mark Hackett

Managing Partner And Co-Founder

Lana B. Caron

General Partner

Michael Hoey

General Partner

Terry Adams

General Partner

MBA FFPM GFMD Laurent Pacheco

Investor Venture Partner

A. Travis Manasco

Principal

Joshua Eckelberry

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersChattanooga, Tennessee
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.